Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Small Cell Lung Carcinoma 15Lung Neoplasms 5Neoplasms 4Sarcoma 3Sarcoma, Ewing 2Neuroendocrine Tumors 2Desmoplastic Small Round Cell Tumor 2Stomach Neoplasms 1SCLC, Extensive Stage 1Platinum-Resistant Lung Small Cell Carcinoma 1Ovarian Neoplasms 1Neutropenia 1Mesothelioma 1Leiomyosarcoma 1Glioblastoma 1Gastrointestinal Malignancies 1Gastro-enteropancreatic neuroendocrine tumor 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma, Small Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1Advanced Solid Tumor 1Adenoma, Islet Cell 1

Interventions

Injections 20Carboplatin 9pembrolizumab 8Bevacizumab 6Pemetrexed 5Paclitaxel 5Leucovorin 5Fluorouracil 5fludarabine 4Oxaliplatin 4Docetaxel 4sotorasib 3atezolizumab 3Drug Therapy 3Cyclophosphamide 3Capecitabine 3trifluridine tipiracil drug combination 2trametinib 2toripalimab 2spartalizumab 2palbociclib 2olaparib 2Panitumumab 2Immune Checkpoint Inhibitors 2Fulvestrant 2Etoposide 2Cisplatin 2Cetuximab 2130-nm albumin-bound paclitaxel 2zimberelimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumors × PM 01183 × 1 year × Clear all
NCT05063318 2025-09-02

Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors

PharmaMar

Phase 1 Completed
14 enrolled 20 charts
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡